Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.85 USD | -1.16% | +4.54% | +175.95% |
02:21pm | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
09/05 | Q32 Bio Inc. Provides Corporate Update | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+175.95% | 360M | |
+8.19% | 115B | |
+13.09% | 107B | |
-13.42% | 22.31B | |
-3.99% | 21.6B | |
-5.62% | 18.23B | |
-39.93% | 17.62B | |
+7.73% | 14.26B | |
+33.69% | 12.37B | |
-28.32% | 8.28B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- RBC Downgrades Homology Medicines to Sector Perform From Outperform, Price Target Slashed to $4 From $30, Shares Fall 25%